课题基金 / 基金详情

ORAL CONTRACEPTIVES, HORMONAL RISK FACTORS AND BRCA1

ORAL CONTRACEPTIVES, HORMONAL RISK FACTORS AND BRCA1
口服避孕药、激素风险因素和 BRCA1
批准号:
6563754
负责人:
GISKE URSIN
金额:
$15.75万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-01 至 2003-01-31

项目摘要

项目成果

GISKE URSIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(申请人描述)项目C:口服避孕药, 激素危险因素和BRCA1。乳腺癌中的突变 易感基因BRCA1可能与相当数量的乳房有关 在很小的时候就诊断出癌症。然而,乳腺癌的年龄 发病率似乎有很大的差异,即使在来自同一家庭的女性中也是如此 同样的突变。这表明,遗传或非遗传的其他因素 在BRCA1基因携带者是否或何时发生乳腺癌中发挥作用 突变。 流行病学证据表明,早期使用口服避孕药(OC) 年龄可能会增加患乳腺癌的风险。此外,OC的使用可以具体地 对有家族病史的女性不利。一些环境风险 使用外源激素以外的其他因素可能也通过荷尔蒙发挥作用 机制;包括第一个孩子的年龄、产次、可能的流产,以及 体育锻炼。所有这些因素都是可以操纵的,因此具有 对预防的影响。这些“荷尔蒙”风险因素似乎有 有家族史的女性与有家族史的女性的影响不同,如果不是相反的话 没有这样的历史的女性。这其中的原因不得而知。然而,BRCA1 在实验研究中,基因的表达似乎受到激素的调节。 此外,有家族史的女性更有可能发生BRCA1突变。 因此,家庭修改的表面效果可能是 历史是由BRCA1状态引起的。 我们建议进行一项以人口为基础的研究,调查 特定BRCA1突变的存在改变了1)口服的效果 避孕措施的使用,2)“荷尔蒙”危险因素的影响,如年龄 第一次生育、怀孕次数和堕胎次数,以及3) 体育锻炼对乳腺癌风险的保护作用。此外, 这项研究将提供有关这些突变的频率的信息 更年轻的乳腺癌患者,我们将探索两者之间的联系 BRCA1状态和其他乳腺癌危险因素,如乳房X光检查 密度。 这项研究将提供有关该角色的有价值的流行病学信息。 BRCA1在乳腺癌病因学中的作用,并可能在 为患有老年痴呆症的妇女制定干预方案和适当的咨询 BRCA1突变。
英文摘要
Description: (Applicant's Description) Project C: Oral Contraceptives, Hormonal Risk Factors, and BRCA1. Mutations in the breast cancer susceptibility gene BRCA1 may be involved in a substantial number of breast cancers diagnosed at an early age. However, the age at which breast cancer occurs appears to vary substantially, even in women from the same family with the same mutation. This suggests that other, genetic or non-genetic, factors play a role in whether or when breast cancer occurs in women with a BRCA1 mutation. Epidemiological evidence suggests that oral contraceptive (OC) use at an early age may increase risk of breast cancer. Further, OC use may be particularly detrimental in women with a family history. A number of environmental risk factors other than exogenous hormone use probably also work through a hormonal mechanism; these include age at first birth, parity, possibly abortion, and physical exercise. All these factors can be manipulated, and therefore have implications for prevention. These "hormonal" risk factors appear to have different, if not opposite, effects in women with a family history than in women with no such history. The reason for this is unknown. However, BRCA1 expression appears to be regulated by hormones in experimental studies. Further, women with a family history are more likely to have a BRCA1 mutation. It is therefore possible that the apparent effect modification by family history is caused by BRCA1 status. We propose to conduct a population-based study that investigates whether the presence of specific BRCA1 mutations modify 1) the effects of oral contraceptive use, 2) the effects of "hormonal" risk factors such as age at first birth, number of pregnancies, and number of abortions, and 3) the protective effect of physical exercise, on breast cancer risk. In addition, this study will provide information as to the frequency of these mutations in younger breast cancer patients, and we will explore the associations between BRCA1 status and other breast cancer risk factors such as mammographic densities. This study will provide valuable epidemiologic information regarding the role of BRCA1 in breast cancer etiology, and could yield important results in developing intervention regimens and appropriate counseling for women with a BRCA1 mutation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mammographic density, genes and estradiol/norethisterone based EPT regimens
Mammographic density, genes and estradiol/norethisterone based EPT regimens
HT, Mammographic Densites and Breast Cancer
GENES AND THE ESTROGEN EFFECT ON ENDOMETRIAL CANCER
海外基金